Nisa Investment Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $29.5K | Buy |
7,082
+5,691
| +409% | +$21.6K | ﹤0.01% | 2064 |
|
|
2026
Q1 | $4.88K | Buy |
1,391
+113
| +9% | +$361 | ﹤0.01% | 2460 |
|
|
2025
Q4 | $3.49K | Sell |
1,278
-1,976
| -61% | -$4.57K | ﹤0.01% | 2518 |
|
|
2025
Q3 | $7.06K | Buy |
3,254
+561
| +21% | +$1.32K | ﹤0.01% | 2370 |
|
|
2025
Q2 | $4.63K | Sell |
2,693
-5,619
| -68% | -$14K | ﹤0.01% | 2463 |
|
|
2025
Q1 | $27.7K | Buy |
8,312
+377
| +5% | +$1.94K | ﹤0.01% | 1763 |
|
|
2024
Q4 | $58.7K | Sell |
7,935
-374
| -5% | -$3.47K | ﹤0.01% | 1641 |
|
|
2024
Q3 | $78K | Buy |
8,309
+235
| +3% | +$2.23K | ﹤0.01% | 1515 |
|
|
2024
Q2 | $64.8K | Buy |
8,074
+332
| +4% | +$3.56K | ﹤0.01% | 1588 |
|
|
2024
Q1 | $115K | Buy |
7,742
+201
| +3% | +$2.34K | ﹤0.01% | 1433 |
|
|
2023
Q4 | $61.3K | Buy |
7,541
+5,577
| +284% | +$29.2K | ﹤0.01% | 1584 |
|
|
2023
Q3 | $8.94K | Sell |
1,964
-3,872
| -66% | -$25.3K | ﹤0.01% | 2192 |
|
|
2023
Q2 | $41.1K | Buy |
5,836
+1,965
| +51% | +$14.1K | ﹤0.01% | 1817 |
|
|
2023
Q1 | $24K | Buy |
3,871
+1,995
| +106% | +$13.8K | ﹤0.01% | 1954 |
|
|
2022
Q4 | $12K | Sell |
1,876
-4,562
| -71% | -$35.6K | ﹤0.01% | 2168 |
|
|
2022
Q3 | $60K | Sell |
6,438
-176
| -3% | -$2.03K | ﹤0.01% | 1680 |
|
|
2022
Q2 | $73K | Buy |
6,614
+6,190
| +1,460% | +$81.1K | ﹤0.01% | 1597 |
|
|
2022
Q1 | $7K | Hold |
424
| – | – | ﹤0.01% | 2257 |
|
|
2021
Q4 | $7K | Sell |
424
-396
| -48% | -$8.72K | ﹤0.01% | 2067 |
|
|
2021
Q3 | $20K | Sell |
820
-5,549
| -87% | -$131K | ﹤0.01% | 2095 |
|
|
2021
Q2 | $166K | Hold |
6,369
| – | – | ﹤0.01% | 1470 |
|
|
2021
Q1 | $202K | Hold |
6,369
| – | – | ﹤0.01% | 1485 |
|
|
2020
Q4 | $296K | Buy |
6,369
+578
| +10% | +$22.9K | ﹤0.01% | 1331 |
|
|
2020
Q3 | $191K | Sell |
5,791
-454
| -7% | -$13.9K | ﹤0.01% | 1321 |
|
|
2020
Q2 | $171K | Buy |
6,245
+5,384
| +625% | +$177K | ﹤0.01% | 1320 |
|
|
2020
Q1 | $26K | Buy |
861
+160
| +23% | +$4.24K | ﹤0.01% | 1661 |
|
|
2019
Q4 | $19K | Hold |
701
| – | – | ﹤0.01% | 1699 |
|
|
2019
Q3 | $13K | Sell |
701
-249
| -26% | -$5.51K | ﹤0.01% | 1718 |
|
|
2019
Q2 | $23K | Hold |
950
| – | – | ﹤0.01% | 1585 |
|
|
2019
Q1 | $9K | Sell |
950
-250
| -21% | -$2.43K | ﹤0.01% | 1787 |
|
|
2018
Q4 | $11K | Buy |
1,200
+690
| +135% | +$6.66K | ﹤0.01% | 1628 |
|
|
2018
Q3 | $6K | Sell |
510
-190
| -27% | -$2.7K | ﹤0.01% | 1849 |
|
|
2018
Q2 | $9K | Hold |
700
| – | – | ﹤0.01% | 1757 |
|
|
2018
Q1 | $12K | Buy |
+700
| New | +$10.6K | ﹤0.01% | 1596 |
|
Other funds holding IOVA
MFM
PAI
Nisa Investment Advisors's IOVA Position: Q2 2026 in Review
Nisa Investment Advisors increased its Iovance Biotherapeutics (IOVA) stake by 409% in Q2 2026, buying an estimated $21.6K and bringing the position to 7,082 shares worth $29.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2064.
Nisa Investment Advisors first reported a position in IOVA in Q1 2018 and has held it in 34 quarters since. The position peaked at $296K in Q4 2020. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.
- Nisa Investment Advisors held 7,082 shares of Iovance Biotherapeutics worth $29.5K as of Q2 2026.
- Nisa Investment Advisors bought 5,691 Iovance Biotherapeutics shares in Q2 2026, an estimated $21.6K.
- Iovance Biotherapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2064 holding.
- Nisa Investment Advisors first reported a position in Iovance Biotherapeutics in Q1 2018 and has held it in 34 quarters since.
- Nisa Investment Advisors's Iovance Biotherapeutics position peaked at $296K in Q4 2020.
- 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.
Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.